Therapeutic Equivalence Study comparing BP16 (Proposed Denosumab Biosimilar) and Reference Denosumab in Postmenopausal Women with Osteoporosis

Fugevy (denosumab biosimilar) - CuraTeQ Biologics

https://asbmr.confex.com/asbmr/2026/meetingapp.cgi/Paper/7484

Richard Eastell 1; Anna Strzelecka, MD 2; Katarzyna Bartnicka-Maslowska, M.D 3; Jerzy Supronik, M.D, Ph.D 4; Anna Platek, M.D, Ph.D 3; Disha Dadke, Ph.D 5; Arpitkumar Prajapati, M.D 5

Jul 31, 2026